About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
I
Personalizing Our Approach: A Focus on Targeting Diabetes with Concomitant CKD
By
KDIGO
FEATURING
Ian De Boer
,
Natasha Mcintyre
By
KDIGO
FEATURING
Ian De Boer
,
Natasha Mcintyre
151 views
June 19, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:01
Lilly Diabetes
Discover the MOA of an Incretin Medication for T2D
Featured Video
04:47
Novartis Cardiology
Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowe…
Related Content
AUTOPLAY
ON
06:38
Allan Jaffe
What Does Elevated Troponin Mean in COVID-19?
11:25
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
Feat.
A. Armbruster
20:15
Omnipod®
Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D
Feat.
F. Pasquel
36:53
University of Colorado Department of Medicine
ADPKD: Breakthroughs and Updates
Feat.
M. Chondol
15:06
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
37:21
University of Colorado Department of Medicine
Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…
Feat.
R. Johnson
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…
Feat.
R. DeFronzo
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
16:08
Omnipod®
Unlock the Future of Type 2 Diabetes Care (featuring Dr. Viral Shah)
Feat.
V. Shah
21:33
AdventHealth
FLOW: The First Dedicated CKD Outcomes Trial With a GLP-1 Receptor A…
Feat.
R. Pratley
26:49
Diana Isaacs
Tirzepatide Updates
33:23
Keck School of Medicine of USC
Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…
Feat.
M. Goran
08:35
Susan Brian
Labs to Check on Semaglutide or Tirzepatide
21:19
Patricia Kao
Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…
07:41
Susan Brian
Weightloss in Menopause
19:26
Krista Varady
ADA 2022 Flipping the Metabolic Switch: Intermittent Fasting as a We…
06:31
Susan Brian
Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist
19:23
PKD Foundation
Genetic Testing in PKD: The Benefits and the Challenges
Feat.
L. Noureddine
11:07
Susan Brian
Wegovy 2024 Updates
05:08
Susan Brian
The Differences Between the Products of GLP1's and GLP/GIPs
